Trial Profile

An Open-label, Phase I Study of NEO-PTC-01 in Patients With Advanced or Metastatic Melanoma

Status: Discontinued

Phase of Trial: Phase I

Latest Information Update: 10 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BNT 221 (Primary)
Indications Malignant melanoma; Solid tumours
Focus Adverse reactions; First in man
Sponsors BioNTech; Neon Therapeutics

Most Recent Events

06 Apr 2025 Status changed from active, no longer recruiting to discontinued.
01 Mar 2025 Results assessing safety data published in the Nature Medicine
19 Dec 2024 Planned End Date changed from 31 Oct 2025 to 1 Dec 2029.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com